Gasser T, Müller-Myhsok B, Wszolek Z K, Oehlmann R, Calne D B, Bonifati V, Bereznai B, Fabrizio E, Vieregge P, Horstmann R D
Neurologische Klinik, Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany.
Nat Genet. 1998 Mar;18(3):262-5. doi: 10.1038/ng0398-262.
Parkinson's disease (PD) is a common degenerative neurologic disorder, which is pathologically characterized by a selective degeneration of dopaminergic neurons of the substantia nigra pars compacta, and the presence of characteristic eosinophilic inclusions, known as Lewy-bodies in affected brain areas. The cause of PD is unknown but, in recent years, genetic factors have been implicated in the aetiology of the disease. Firstly, clinico-genetic, epidemiologic and twin studies revealed inheritable effects and questioned earlier studies which had denied such influences. Secondly, several family studies suggested autosomal-dominant inheritance of syndromes which, to variable degrees, resembled sporadic PD clinically and in some cases also neuropathologically. Recently, a disease locus has been mapped to chromosome 4q21-22 in a large Mediterranean pedigree, in which disease expression is clinically and pathologically within the spectrum of sporadic PD; being atypical only for a relatively young mean age at onset of 46 years and rapid course of 10 years from onset to death. In affected individuals of this family and of three unrelated Greek kindreds, a putative disease-causing mutation has been identified in the gene encoding alpha-synuclein. With the first variant being defined, genetic heterogeneity has become apparent, as in other families parkinsonism was not linked to the 4q-locus and was not associated with the alpha-synuclein mutation (unpublished data). We describe a different genetic locus that appears to be involved in the development of parkinsonism closely resembling sporadic PD including a similar mean age of onset (59 years in the families, 59.7 years in sporadic PD; ref. 12). This locus was detected in a group of families of European origin. In two of these families, there is genetic evidence for a common founder. The penetrance of the mutation appears to be low, most likely below 40%. This is compatible with a possible role of this locus not only in familial, but also in typical (sporadic) PD.
帕金森病(PD)是一种常见的退行性神经疾病,其病理特征为黑质致密部多巴胺能神经元的选择性退化,以及在受影响脑区存在特征性嗜酸性包涵体,即路易小体。PD的病因尚不清楚,但近年来,遗传因素已被认为与该疾病的病因有关。首先,临床遗传学、流行病学和双胞胎研究揭示了遗传效应,并对早期否认此类影响的研究提出了质疑。其次,几项家族研究表明,某些综合征呈常染色体显性遗传,这些综合征在临床和某些情况下在神经病理学上与散发性PD有不同程度的相似性。最近,在一个大型地中海家系中,一个疾病位点已被定位到染色体4q21 - 22,该家系中的疾病表现无论在临床还是病理上都处于散发性PD的范围内;唯一不典型的是发病的平均年龄相对较小,为46岁,且从发病到死亡病程仅10年。在这个家系以及三个无关的希腊家族的患病个体中,已在编码α - 突触核蛋白的基因中鉴定出一个假定的致病突变。随着第一个变异体的确定,遗传异质性变得明显,因为在其他家族中,帕金森病与4q位点没有连锁关系,也与α - 突触核蛋白突变无关(未发表数据)。我们描述了一个不同的遗传位点,它似乎与酷似散发性PD的帕金森病的发生有关,包括相似的发病平均年龄(家族中为59岁,散发性PD中为59.7岁;参考文献12)。这个位点是在一组欧洲血统的家族中检测到的。在其中两个家族中,有遗传证据表明存在共同的祖先。该突变的外显率似乎较低,很可能低于40%。这与该位点不仅在家族性PD,而且在典型(散发性)PD中可能发挥的作用是相符的。